Drug Landscape ›
factor VIII ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 2,008
Most-reported reactions
Pharmaceutical Product Complaint — 587 reports (29.23%) Adverse Event — 555 reports (27.64%) Haemorrhage — 219 reports (10.91%) Drug Ineffective — 158 reports (7.87%) Hiv Infection — 94 reports (4.68%) Haemarthrosis — 88 reports (4.38%) Hepatitis C Virus — 88 reports (4.38%) Factor Viii Inhibition — 87 reports (4.33%) Hepatitis C — 75 reports (3.74%) Acquired Haemophilia — 57 reports (2.84%)
Source database →
factor VIII in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is factor VIII approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for factor VIII in United States?
Novo Nordisk A/S is the originator. The local marketing authorisation holder may differ — check the official source linked above.